SGLT1 and SGLT2 are functionally expressed on human prostate and pancreas cancers, and Cana treatment of a pancreas cancer xenograft potentiated the effects of genotoxic chemotherapy (41). Here, SLC5A2 is linked to pancreatic neoplasm.